In Setback For Mylan, Judge Upholds Levaquin Patent

Law360 (January 2, 2005, 12:00 AM EST) -- A federal judge has barred Mylan Laboratories Inc. from making a generic version of the antibiotic Levaquin until at least December 2010.

Last week, U.S. District Judge Irene M. Keeley prohibited Mylan from making or selling levofloxacin tablets, a generic form of Levaquin.

The drug is used to treat a variety of conditions, including bronchitis, sinusitis and urinary tract infections.

Ortho-McNeil Pharmaceutical Inc., a Johnson & Johnson company that sells Levaquin in the U.S., and Japanese patent-owner Daiichi Pharmaceutical Co. had filed their first lawsuit in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.